DGAP-News: curasan AG / Key word(s): AGM/EGM
30.01.2019 / 07:36
The issuer is solely responsible for the content of this announcement.
– Shareholders approve authorization to issue convertible bonds
– Election of Isabella de Krassny to the Supervisory Board
– Presentation of the strategic realignment of curasan AG
Kleinostheim, 30 January 2019 – curasan AG, Germany, a leading specialist for medical products in the field of orthobiologics, has held an extraordinary general meeting yesterday in Aschaffenburg, which had been convened due to the announcement of the loss of half of the share capital.
In his speech, CEO Michael Schlenk explained the reasons for the current company situation to the shareholders present (31.1% percent of the company’s share capital at the time of the vote) and stressed the importance of the approval of the Annual General Meeting of the authorization of the Executive Board to issue convertible bonds with the approval of the Supervisory Board for the implementation of a necessary strategic realignment. He outlined the accompanying measures, including a possible company acquisition after the successful issue of convertible bonds, within the next few weeks.
Isabella de Krassny, who had already been appointed by the court as a member of the Supervisory Board since January 1, 2019, introduced herself to the shareholders. The Supervisory Board and the Management Board asked the Annual General Meeting to confirm her in this office by election – for the remaining term of office of Supervisory Board member Professor Dr. Dirk Honold, who resigned at the end of 31 December 2018, i.e. presumably until the Annual General Meeting in 2022.
The Annual General Meeting approved all agenda items in accordance with the management’s proposals.
In detail, agenda items 2 and 3 were approved with the following percentage of voting shares:
Agenda item 2: 95.06%
Further details on the agenda items put to the vote as well as the presentation at today’s Annual General Meeting can be found on the German website of curasan AG under http://www.curasan.de/investoren/hauptversammlung/.
Contact at curasan AG:
About curasan AG:
30.01.2019 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Phone:||06027/40 900 0|
|Fax:||06027/40 900 29|
|Listed:||Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange|
|End of News||DGAP News Service|